PPD and HealthCore are building upon their existing collaboration to include Evidera, PPD's peri- and post-approval business unit. The addition of Evidera will help enable the companies to address post-marketing safety commitments in Europe and the U.S., and expand the relationship to include other studies evaluating outcomes in real-world settings. PPD and HealthCore first established this collaboration in 2015 [...]The post PPD, HealthCore expand real-world research capabilities appeared first on CenterWatch News Online.
Evidera is a Maryland-based company that offers services such as medical writing and development consulting for biopharmaceutical and biotechnology markets.